Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
21 hedge funds and large institutions have $9.3M invested in Nymox Pharmaceutical Corp in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 4 closing their positions.
200% more call options, than puts
Call options by funds: $3K | Put options by funds: $1K
40% more capital invested
Capital invested by funds: $6.62M → $9.3M (+$2.68M)
0.23% more ownership
Funds ownership: 2.99% → 3.22% (+0.23%)
16% less funds holding
Funds holding: 25 → 21 (-4)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$153K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$3.33K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$28 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
WMS Partners
Towson,
Maryland
|
-$27K |
| 2 |
AIG
American International Group
New York
|
-$22.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$13.3K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$13K |
| 5 |
BAC
Boys Arnold & Co
Asheville,
North Carolina
|
-$5K |
NYMX Hedge Fund Activity: Q1 2015 in Review
21 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2015, worth a combined $9.3M — up 40% from $6.62M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NYMX and 0 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 3 added.
The largest buyer was Advisors Asset Management, adding an estimated $153K. The largest seller was WMS Partners, exiting entirely with an estimated $27K sold.
- 21 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2015, down from 25 in Q4 2014.
- Funds reported $9.3M of Nymox Pharmaceutical Corp stock for Q1 2015, up 40% quarter-over-quarter.
- 0 funds opened new Nymox Pharmaceutical Corp positions in Q1 2015 and 4 closed out, a net change of -4 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q1 2015 was Advisors Asset Management, an estimated $153K added.
- The largest Nymox Pharmaceutical Corp seller in Q1 2015 was WMS Partners, an estimated $27K sold.
Based on aggregated 13F filings for Q1 2015.